Literature DB >> 1859876

Autoantibody activity of immunoglobulins isolated from B-cell follicular lymphomas.

G Dighiero1, S Hart, A Lim, L Borche, R Levy, R A Miller.   

Abstract

Previous work with monoclonal Igs (MIgs) has demonstrated that a high proportion of paraproteins bind to self-antigens such as the Fc fragment of IgG, Ii blood group antigens, cytoskeleton proteins, DNA, and myelin-associated glycoprotein (MAG). Recent work in CLL indicates that CD5+ B lymphocytes are frequently committed to production of autoantibodies. We have examined the antibody specificity of MIgs derived from the tumor cells of 31 different patients with CD5- B-cell lymphomas. Our results indicate that the tumor cells from 8 of these 31 patients (25.8%) express Igs with autoantibody activity. In two cases antibody activity was multispecific. In four cases, antibody activity was exclusively directed against the Fc fragment of IgG, whereas the two other cases bound to both Fc fragment of IgG and nuclear antigens. Most non-Hodgkin's lymphomas (NHL) are derived from CD5- B cells. These results indicate that like CLL, NHL also express Igs that frequently have autoantibody activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1859876

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Self-antigen recognition by follicular lymphoma B-cell receptors.

Authors:  Kacey L Sachen; Michael J Strohman; Jonathan Singletary; Ash A Alizadeh; Nicole H Kattah; Chen Lossos; Elizabeth D Mellins; Shoshana Levy; Ronald Levy
Journal:  Blood       Date:  2012-09-28       Impact factor: 22.113

2.  Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type.

Authors:  T Hussell; P G Isaacson; J E Crabtree; A Dogan; J Spencer
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

3.  Multiple autoantibody production in a patient with splenic lymphoma.

Authors:  M Sawamura; S Yamaguchi; H Murakami; H Amagai; T Matsushima; J Tamura; T Naruse; J Tsuchiya
Journal:  Ann Hematol       Date:  1994-05       Impact factor: 3.673

Review 4.  Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.

Authors:  Maike Buchner; Markus Müschen
Journal:  Curr Opin Hematol       Date:  2014-07       Impact factor: 3.284

5.  Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen.

Authors:  Soung-Chul Cha; Hong Qin; Shibichakravarthy Kannan; Seema Rawal; Leticia S Watkins; Flavio E Baio; Weiguo Wu; Juliana Ong; Jinsong Wei; Benjamin Kwak; Sang Kim; Michael S Popescu; Daniel S Paick; Kunhwa Kim; Amber Luong; Richard E Davis; Harry W Schroeder; Larry W Kwak; Sattva S Neelapu
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

6.  Follicular lymphoma of the thyroid gland.

Authors:  Chris M Bacon; Timothy C Diss; Hongtao Ye; Hongxiang Liu; Alison Goatly; Rifat Hamoudi; Andrew Wotherspoon; Randy D Gascoyne; Ahmet Dogan; Ming-Qing Du; Peter G Isaacson
Journal:  Am J Surg Pathol       Date:  2009-01       Impact factor: 6.394

7.  Clonal evolution of a follicular lymphoma: evidence for antigen selection.

Authors:  D W Bahler; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 8.  Immunoglobulin variable region structure and B-cell malignancies.

Authors:  H Kiyoi; T Naoe
Journal:  Int J Hematol       Date:  2001-01       Impact factor: 2.319

9.  Stereotypical chronic lymphocytic leukemia B-cell receptors recognize survival promoting antigens on stromal cells.

Authors:  Mascha Binder; Barbara Léchenne; Ramesh Ummanni; Christan Scharf; Stefan Balabanov; Maria Trusch; Hartmut Schlüter; Ingke Braren; Edzard Spillner; Martin Trepel
Journal:  PLoS One       Date:  2010-12-30       Impact factor: 3.240

Review 10.  Targeting Bruton's Tyrosine Kinase in CLL.

Authors:  Inhye E Ahn; Jennifer R Brown
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.